Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart’s Top Stock Pick. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Ultragenyx Pharmaceu (RARE)

Ultragenyx Pharmaceu (RARE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Ultragenyx Pharmaceu 60 Leveroni Court Novato CA 94949 USA

P: 415-483-8800 F: 415-483-8810

Description:

Ultragenyx Pharmaceutical Inc. is focused on the identification, acquisition, development and commercialization of novel products for the treatment of rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases.

Key Statistics

Overview:

Market Capitalization, $K 2,840,000
Enterprise Value, $K 2,099,810
Shares Outstanding, K 70,037
Annual Sales, $ 351,410 K
Annual Net Income, $ -454,030 K
Last Quarter Sales, $ 89,340 K
Last Quarter Net Income, $ -158,160 K
60-Month Beta 1.23
% of Insider Shareholders 6.70%
% of Institutional Shareholders 88.27%
Float, K 65,345
% Float 93.30%
Short Volume Ratio 0.33

Growth:

1-Year Return -54.09%
3-Year Return -6.99%
5-Year Return -23.75%
5-Year Revenue Growth 270,215.41%
5-Year Earnings Growth -2.09%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -2.26 on 07/28/22
Next Earnings Date 11/01/22
Earnings Per Share ttm -7.32
EPS Growth vs. Prev Qtr -3.20%
EPS Growth vs. Prev Year -55.86%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

RARE Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -60.76%
Return-on-Assets % -35.43%
Profit Margin % -129.20
Net Margin % N/A
Debt/Equity 0.00
Price/Sales 8.23
Price/Cash Flow N/A
Price/Book 4.26
Book Value/Share 9.68
Interest Coverage -14.40
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar